Cargando…
Extracardiac Prothrombotic Effects of COVID-19
COVID-19 infection triggers a heightened inflammatory response which in turn, increases thrombosis and thromboembolism. Microvascular thrombosis has been detected in various tissue beds which may account for some of the multi-system organ dysfunction associated with COVID-19. Additional research is...
Autores principales: | Kankaria, Rohan, Sanina, Cristina, Gabr, Mohamed, Wiley, Jose, Bortnick, Anna E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973540/ https://www.ncbi.nlm.nih.gov/pubmed/36863813 http://dx.doi.org/10.1016/j.hfc.2022.08.008 |
Ejemplares similares
-
Extracardiac Prothrombotic Effects of COVID-19
por: Kankaria, Rohan, et al.
Publicado: (2022) -
Prothrombotic Phenotype in COVID-19: Focus on Platelets
por: Barale, Cristina, et al.
Publicado: (2021) -
Prothrombotic status in COVID‑19 with diabetes mellitus (Review)
por: Mitroi, Roxana Madalina, et al.
Publicado: (2023) -
Beneficial Extracardiac Effects of Cardiovascular Medications
por: Butt, Asra K., et al.
Publicado: (2022) -
Inflammatory response in relation to COVID-19 and other prothrombotic phenotypes()
por: Páramo, José A.
Publicado: (2022)